Related references
Note: Only part of the references are listed.Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair
C. Barckhausen et al.
ONCOGENE (2014)
The role of stereotactic radiosurgery for multiple brain metastases in stable systemic disease: a review of the literature
Siri Sahib S. Khalsa et al.
ACTA NEUROCHIRURGICA (2013)
Molecular aspects of cancer cell resistance to chemotherapy
Magali Rebucci et al.
BIOCHEMICAL PHARMACOLOGY (2013)
DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy
Emil Mladenov et al.
FRONTIERS IN ONCOLOGY (2013)
A Review of Current Management of Brain Metastases
Xiang Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers
Marieke A. Vollebergh et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
A nomogram for individualized estimation of survival among patients with brain metastasis
Jill S. Barnholtz-Sloan et al.
NEURO-ONCOLOGY (2012)
The Role of Whole Brain Radiation Therapy for the Management of Brain Metastases in the Era of Stereotactic Radiosurgery
Eisuke Abe et al.
CURRENT ONCOLOGY REPORTS (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Martin Kocher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
Shivaani Kummar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Current Management of Metastatic Brain Disease
Tulika Ranjan et al.
NEUROTHERAPEUTICS (2009)
How to build and interpret a nomogram for cancer prognosis
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
Jeffrey M. Albert et al.
CLINICAL CANCER RESEARCH (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
Brain metastases: epidemiology and pathophysiology
IT Gavrilovic et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews et al.
LANCET (2004)
Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer
MW Kattan
CURRENT OPINION IN UROLOGY (2003)
Strategies for increasing drug delivery to the brain - Focus on brain lymphoma
T Siegal et al.
CLINICAL PHARMACOKINETICS (2002)
Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma
M Shiobara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Share Paper
